Patents Assigned to Research Institute for Genetic and Human Therapy (R.I.G.H.T.)
  • DNA composition and uses thereof
    Patent number: 7196186
    Abstract: A plasmid DNA that encodes one or more antigenic genes operably linked to a promoter and a truncated retroviral 3? LTR exhibits both enhanced safety and acceptable efficiency of expression of antigenic proteins.
    Type: Grant
    Filed: January 14, 2004
    Date of Patent: March 27, 2007
    Assignee: Research Institute for Genetic and Human Therapy (R.I.G.H.T.)
    Inventors: Julianna Lisziewicz, Jianqing Xu, Franco Lori
  • Method of inhibiting human immunodeficiency virus using hydroxurea and a reverse transcriptase inhibitor in vivo
    Patent number: 6251874
    Abstract: A method for treating HIV infection in human beings comprising the step of measuring viremia, and if viremia is less than 50,000-100,00 copies per milliliter, administering a combination of compounds selected from the group consisting of hydroxyurea, and one or more reverse transcriptase inhibitors.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: June 26, 2001
    Assignee: Research Institute for Genetic and Human Therapy (R.I.G.H.T.)
    Inventors: Julianna Lisziewicz, Franco Lori
  • Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor
    Patent number: 6114312
    Abstract: A method for inhibiting replication of reverse transcriptase dependent virus in plant or animal cells, comprising the step of administering to said cells a combination of compounds selected from the group consisting of hydroxyurea, a nucleoside analog, and a protease inhibitor.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: September 5, 2000
    Assignee: Research Institute for Genetic and Human Therapy (R.I.G.H.T.)
    Inventors: Julianna Lisziewicz, Franco Lori